Target intelligence / Profile preview

Small Cajal body-specific RNA 15 (SCARNA15)

Target
SCARNA15
Molecular classification
Other (specifically: small nucleolar RNA, H/ACA box scaRNA)
01

Overview

Small Cajal body-specific RNA 15 (SCARNA15), also known as ACA45, is a small nucleolar RNA localized in Cajal bodies, a subnuclear organelle. SCARNA15 belongs to the H/ACA box class of scaRNAs and primarily guides the pseudouridylation (isomerisation of uridine to pseudouridine) of specific uridine residues in spliceosomal small nuclear RNAs, especially U2 snRNA (notably at position U39)[3][2]. Through directing this RNA modification, SCARNA15 fine-tunes alternative splicing of transcripts involved in chromatin regulation and transcription, impacting the function of key tumor suppressors such as p53 and ATRX[1][2][5]. Loss of SCARNA15 disrupts redox homeostasis, increases sensitivity to oxidative stress, and impairs cancer cell survival and motility, indicating its importance in maintaining stress adaptation and contributing to cancer-associated splicing programs[1][2][5]. SCARNA15 is not a protein, receptor, enzyme, or typical therapeutic target, but rather a regulatory noncoding RNA implicated in post-transcriptional gene regulation and splicing fidelity in both normal and malignant contexts[1][2][3][5].

Other names
ACA45ACA45 scaRNA
02

Biological functions

RNA splicingPost-transcriptional modificationRegulation of alternative splicingRedox homeostasisRegulation of tumor suppressor pathways (p53, ATRX)
03

Disease associations

CancerOther (notably, dysregulation may contribute to tumorigenesis and cancer cell survival pathways)

Beyond the preview

Go deeper on Small Cajal body-specific RNA 15 (SCARNA15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small Cajal body-specific RNA 15 (SCARNA15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call